TREATMENT
Clinical trials for TREATMENT explained in plain language.
Never miss a new study
Get alerted when new TREATMENT trials appear
Sign up with your email to follow new studies for TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made cancer vaccine shows promise in advanced tumors
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a personalized vaccine made from a patient's own immune cells (dendritic cells) that are trained to attack unique markers on their tumor. It is for people aged 18-75 with advanced solid tumors who have not responded to standard treatments. The goal is to see if t…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Fudan University • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:03 UTC
-
New hope for ITP patients: daratumumab takes on rituximab in head-to-head trial
Disease control Recruiting nowThis study compares two antibody drugs, daratumumab and rituximab, in 160 adults with immune thrombocytopenia (ITP) whose condition did not improve or came back after steroid treatment. The main goal is to see which drug better raises platelet counts to safe levels by week 12 wit…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 11:46 UTC
-
Could stem cells heal deadly skin wounds in kidney patients?
Disease control Recruiting nowThis study tests a new treatment using stem cells from amniotic membrane for people with calciphylaxis, a rare and painful condition where blood vessels harden and cause severe skin wounds. The treatment is given to 9 adults with chronic kidney disease to see if it helps wounds h…
Matched conditions: TREATMENT
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 17, 2026 11:45 UTC
-
New laser treatment aims to save sight in diabetic patients
Disease control Recruiting nowThis study tests a special laser (micropulse) to treat diabetic macular edema, a common cause of vision loss in people with diabetes. The trial will include 50 adults with diabetes who have central retinal swelling. Researchers will measure changes in vision and retinal thickness…
Matched conditions: TREATMENT
Sponsor: The General Authority for Teaching Hospitals and Institutes • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
New acid blocker may beat old one for stomach bug
Disease control Recruiting nowThis study tests two different acid-reducing medicines (P-CAB and PPI) as part of a four-drug treatment for H. pylori, a stomach infection. About 320 adults who have not been treated before will take one of the two combinations. The goal is to see which approach kills the bacteri…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated May 17, 2026 11:36 UTC
-
Promising Triple-Drug cocktail targets tough leukemia mutation
Disease control Recruiting nowThis study tests a combination of three drugs—venetoclax, ivosidenib, and azacitidine—in adults with acute myeloid leukemia (AML) that has an IDH1 mutation. The goal is to see if this triple therapy can improve remission rates and survival. About 23 participants will receive the …
Matched conditions: TREATMENT
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug combo aims to cut radiation for young hodgkin patients
Disease control Recruiting nowThis study tests whether replacing two standard chemotherapy drugs with brentuximab vedotin can help more children and young adults (ages 2 to 34) with newly diagnosed Hodgkin lymphoma achieve a complete response early in treatment. The goal is to reduce the need for radiation th…
Matched conditions: TREATMENT
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Ancient needles and herbs aim to slow early puberty in girls
Disease control Recruiting nowThis study tests whether a combination of Chinese herbs and intradermal acupuncture can help slow down or reverse early puberty in girls. About 170 girls diagnosed with idiopathic precocious puberty will receive either the treatment or a control. The main goal is to see if breast…
Matched conditions: TREATMENT
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New glasses aim to stop kids' eyesight from getting worse
Disease control Recruiting nowThis study tests two types of special glasses designed to slow the progression of nearsightedness (myopia) in children aged 6 to 14. Participants will wear the glasses daily for one year and attend regular eye exams. The goal is to see which lens design works best and whether the…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for kids with ITP: daratumumab takes on rituximab
Disease control Recruiting nowThis study compares two drugs, daratumumab and rituximab, in children aged 6 to 17 with immune thrombocytopenia (ITP) whose condition did not improve or came back after steroid treatment. ITP causes low platelet counts, leading to bruising and bleeding. The goal is to see which d…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New drug combo aims to boost platelets in Hard-to-Treat ITP
Disease control Recruiting nowThis study tests a combination of two drugs, rituximab and daratumumab, in 20 adults with immune thrombocytopenia (ITP) who did not get better with steroids. The goal is to see if the combination can safely raise platelet counts and reduce bleeding. Participants will receive the …
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New hope for kids with Hard-to-Treat bleeding disorder
Disease control Recruiting nowThis study tests a new drug (anti-CD38 antibody) in 60 children aged 6 and older with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The drug aims to raise platelet counts safely in kids who haven't improved with standard …
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New hope for ITP patients: combo therapy aims to boost platelets
Disease control Recruiting nowThis study tests whether adding an anti-CD38 antibody to the standard drug rituximab works better than rituximab alone for adults with immune thrombocytopenia (ITP) whose platelet counts stayed low or came back after steroid treatment. About 160 participants will receive either t…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 12, 2026 13:44 UTC
-
Scissors vs. electrosurgery: which is better for uterine septum removal?
Symptom relief Recruiting nowThis study compares two surgical techniques for removing a uterine septum, a wall of tissue inside the uterus that can cause problems. Researchers want to see if using scissors without electricity is better than using an electric tool. The study will measure surgery time, costs, …
Matched conditions: TREATMENT
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 17, 2026 11:35 UTC
-
Can a tailored mix of quitting aids finally help stubborn smokers kick the habit?
Symptom relief Recruiting nowThis study aims to improve quitting success for smokers who find it hard to stop with standard medications. About 544 participants will receive free nicotine patches, lozenges, varenicline, or e-cigarettes for 12 weeks, with treatment adjusted based on individual response. All vi…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated May 06, 2026 16:13 UTC
-
Can a simple nerve block predict headache relief?
Knowledge-focused Recruiting nowThis study is looking at what factors in a person's health history might affect how well a nerve block injection works for medication-overuse headache. Researchers will track 70 adults who get the injection and see how their headache days and pain levels change. The goal is to be…
Matched conditions: TREATMENT
Sponsor: Sultan 1. Murat State Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 11:33 UTC